Administration of Δ9-Tetrahydrocannabinol Following Controlled Cortical Impact Restores Hippocampal-Dependent Working Memory and Locomotor Function

Author(s):  
Shijie Song ◽  
Xiaoyuan Kong ◽  
Bangmei Wang ◽  
Juan Sanchez-Ramos
1993 ◽  
Vol 61 (6) ◽  
pp. 2015-2024 ◽  
Author(s):  
Alan M. Palmer ◽  
Donald W. Marion ◽  
Michelle L. Botscheller ◽  
Pamela E. Swedlow ◽  
Scott D. Styren ◽  
...  

2015 ◽  
Vol 57 (2) ◽  
pp. 282-303 ◽  
Author(s):  
Babru B. Samal ◽  
Cameron K. Waites ◽  
Camila Almeida-Suhett ◽  
Zheng Li ◽  
Ann M. Marini ◽  
...  

2004 ◽  
Vol 101 (5) ◽  
pp. 822-825 ◽  
Author(s):  
Dunyue Lu ◽  
Asim Mahmood ◽  
Changsheng Qu ◽  
Anton Goussev ◽  
Mei Lu ◽  
...  

Object. Atorvastatin, a β-hydroxy-β-methylglutaryl coenzyme A reductase inhibitor, has pleiotropic effects such as improving thrombogenic profile, promoting angiogenesis, and reducing inflammatory responses and has shown promise in enhancing neurological functional improvement and promoting neuroplasticity in animal models of traumatic brain injury (TBI), stroke, and intracranial hemorrhage. The authors tested the effect of atorvastatin on intracranial hematoma after TBI. Methods. Male Wistar rats were subjected to controlled cortical impact, and atorvastatin (1 mg/kg) was orally administered 1 day after TBI and daily for 7 days thereafter. Rats were killed at 1, 8, and 15 days post-TBI. The temporal profile of intraparenchymal hematoma was measured on brain tissue sections by using a MicroComputer Imaging Device and light microscopy. Conclusions. Data in this study showed that intraparenchymal and intraventricular hemorrhages are present 1 day after TBI and are absorbed at 15 days after TBI. Furthermore, atorvastatin reduces the volume of intracranial hematoma 8 days after TBI.


2021 ◽  
pp. 1-7
Author(s):  
Dries De Kegel ◽  
Gracia Umuhire Musigazi ◽  
Andrea Menichetti ◽  
Peter-William Hellings ◽  
Raf Sciot ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document